Advisor Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Advisor Group’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1K	Hold	50	–	–	﹤0.01%	5258
2019 Q3	$1K	Hold	50	–	–	﹤0.01%	5218
2019 Q2	$0	Hold	50	–	–	﹤0.01%	5472
2019 Q1	$1K	Hold	50	–	–	﹤0.01%	5160
2018 Q4	$1K	Hold	50	–	–	﹤0.01%	5048
2018 Q3	$1K	Buy	+50	New	+$1.14K	﹤0.01%	5042
2017 Q4	–	Sell	-30	Closed	-$1K	–	5138
2017 Q3	$1K	Sell	30 -329	-92%	-$6.13K	﹤0.01%	4767
2017 Q2	$7K	Sell	359 -35	-9%	-$694	﹤0.01%	4127
2017 Q1	$9K	Sell	394 -603	-60%	-$14.4K	﹤0.01%	3870
2016 Q4	$34K	Buy	997 +804	+417%	+$24K	﹤0.01%	2889
2016 Q3	$5K	Sell	193 -256	-57%	-$6.4K	﹤0.01%	3930
2016 Q2	$10K	Buy	+449	New	+$10.3K	﹤0.01%	3501

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Advisor Group's AMAG Position: Q4 2019 in Review

Advisor Group held its AMAG Pharmaceuticals (AMAG) position steady in Q4 2019 at 50 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5258.

Advisor Group first reported a position in AMAG in Q2 2016 and has held it in 12 quarters since. The position peaked at $34K in Q4 2016. 134 funds tracked by Wall St. Rank hold AMAG as of Q4 2019.

Advisor Group held 50 shares of AMAG Pharmaceuticals worth $1K as of Q4 2019.
Advisor Group left its AMAG Pharmaceuticals share count unchanged in Q4 2019.
AMAG Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5258 holding.
Advisor Group first reported a position in AMAG Pharmaceuticals in Q2 2016 and has held it in 12 quarters since.
Advisor Group's AMAG Pharmaceuticals position peaked at $34K in Q4 2016.
134 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.